:format(jpeg):focal(453x207:463x197)/cloudfront-us-east-1.images.arcpublishing.com/gfrmedia/F5JHGBJ4DJFM7HXBREMVMGRCRA.jpg)
It is an open secret. And, due to educational campaigns about the risks of their use, few dare to say publicly that they use drugs. Less still, the consumption of those known as “psychedelics and dissociatives”, substances that can temporarily change a person’s mood, thoughts, and perceptions of reality, and were banned in the 1970s.
A few weeks ago, the young american rapper Jaden Smithson of actors Will Smith and Jada Pinketthe confessed during a conference on drug use at “Psychedelic Science 2023”, in Denver, that his mother introduced him and his close family circle to the use of psychedelic substances.
The 24-year-old actor also indicated that his consumption helped him have a better relationship with members of his family, especially with his brothers Willow and Trey, because it allowed him to be more empathetic. The reactions and criticism on social networks to this revelation have been multiple. However, the reality is that it is a situation that, apparently, is already quite common.
As reported in various media, In recent years there has been increased interest among researchers in the potential for these drugs to treat a variety of medical conditions, including mental disorders, says psychiatrist Peter Gonzalez, director of External Clinics of the Integrated Health System of the Pan American Hospital.
“More and more people declare that they have used these drugs recreationally and independently of medical use, with the aim of improving their well-being or for spiritual or personal exploration,” explains the psychiatrist, who points out that these substances can temporarily change a person’s mood, thoughts, and perceptions.
“Among other health effects and safety concerns, people who consume these substances report feel strong emotions that can go from joy to fear and experience enormous changes in their way of perceiving reality”, adds the psychiatrist.
According to the World Health Organization (WHO), psychedelic drugs are characterized by their ability to produce distortions in sensations and markedly alter mood and thought processes. “They include substances from a wide variety of natural and synthetic sources and are structurally different from other psychoactive substances. In this sense, it is indicated that they have the pharmacological advantage of inducing these effects very quickly, unlike traditional antidepressants. But, in the same way, it is pointed out that they have the drawback that they induce hallucinations and their use in non-clinically supervised treatments is not recommended.
Meanwhile he National Institute on Drug Abuse (NIDA) of the United States, of the National Institutes of Health (NIH)has indicated that it conducts “research to better understand the health effects of psychedelics and dissociative drugs and to learn if some of them can help treat substance use disorders in medical settings.”
According to the agency, people who use these drugs report feeling strong emotions. “Ranging from intense happiness and a feeling of connectedness, to fear, anxiety and confusion, in addition to visions (hallucinations) or intense or distorted sensations”. It is also estimated these drugs have a role in neuronal plasticity, in addition to a greater antidepressant effect. (Neural plasticity refers to the ability of the nervous system to change its structure and function throughout its life, as an adaptation to the diversity of the environment.)
A week ago, Australia became the first country to prescribe psychedelics for the treatment of certain mental disorders. As published Associated Press (AP), In that country, psychiatrists will be able to prescribe certain psychedelics for patients with depression or post-traumatic stress disorder. “From (next) Saturday, Australian doctors can prescribe doses of MDMA, also known as ecstasy, for post-traumatic stress disorder. Psilocybin, the psychoactive ingredient in hallucinogenic mushrooms, can be administered to people who have difficult-to-treat depression.
In the same way, it is estimated that the United States will give its approval to the therapeutic use of ecstasy before the end of the year, while Canada and Israel have also opened up to the possibility of using it for certain diseases. According to the AP, Oregon was the first state to legalize psilocybin use in adults and Colorado decriminalized it in 2022. “The US Food and Drug Administration (FDA) designated psilocybin as a ‘breakthrough therapy’ in 2018. , a label that is designed to speed the development and review of substances to treat a serious condition. Last month, the FDA published preliminary guidance for the design of clinical trials with psychedelic drugs as potential treatments for medical conditions.
As Dr. Gonzalez explains, many psychedelic drugs are derived from plants and fungi. “and some have been used for thousands of years in traditional or religious rituals.” However, these drugs can also be manufactured in laboratories.
“The FDA conducts and supports research on psychedelics and dissociative drugs to assist in health policy and decisions regarding their use. Researchers are also studying whether some of these substances can serve as effective treatments for mental disorders, including addiction, when administered in a clinical setting. He adds that these drugs, also called “classic psychedelics”, including psilocybin and lysergic acid (LSD), interact primarily with specific receptors that are molecular structures in the brain.
“They are known as receptors for the neurotransmitter (chemical messenger) serotonin. At certain doses, they can trigger vivid visions or sensations, alter a person’s sense of self, and promote feelings of understanding or connection,” adds NIDA.
It is important to note that the main medical and mental health organizations in Australia have rejected psychedelic treatments, as published on its BBC Mundo website. For example, they indicate that the Australian Medical Association (AMA) and the Royal College of Psychiatrists in Australia and New Zealand have also expressed serious concerns. “Both groups have called for larger-scale studies and better research on psychedelic treatments, warning of unknown risks, long-term side effects, and potentially very limited benefits from their use in therapy.”
How safe is its consumption?
According to NIDA, while more research on serious adverse effects from professionally supervised use of certain psychedelics and dissociative drugs is needed, it is relatively low. “Many previous clinical studies on these drugs have not adequately evaluated and reported adverse effects.”
For example, indicate that negative effects can be difficult to predict and depend on many factors. Among them, they mention the amount ingested and potency (concentration and strength), the person’s age, their unique biology, gender, personality, history of drug use, mood, expectations, mindset, and their environment. “The use of psychedelic and dissociative drugs that contain contaminants or their use in combination with other substances may also produce effects not associated with the use of these drugs in isolation,” points out the information, which also highlights that the majority of people who state that they use psychedelic drugs do so outside of medical or research settings.
But some serious adverse effects and safety concerns have also been identified. According to NIDA, the most common short-term events experienced by people who called the poison control hotline between 2000 and 2016 for taking LSD and psilocybin were: agitation, rapid heartbeat, dilated pupils, confusion, and vomiting. They may also feel extreme emotions such as fear, confusion, or panic.
“In addition, they may experience failures in thought and perception processes that lead them to behave in unusual and sometimes dangerous ways. This can lead to injury and other safety issues, especially if there is no one else present who can help prevent or respond to an emergency,” adds the information, after noting that “there is new evidence to suggest that Certain psychedelics and dissociative drugs may contain dangerous adulterant substances..
“Fatal overdose and serious adverse effects are rarely associated with typical use of commonly used psychedelics and dissociative drugs,” the information adds. He also notes that, thus far, mental health complications from these drugs “are extremely rare in clinical research settings.”in part because these studies are highly controlled and participants are screened for existing mental illnesses.”
